Skip to content
Back to treatments
Transplant & Hematology~84% less than U.S.

Stem Cell Transplant for Leukemia

白血病干细胞移植

Duration
4-6 weeks inpatient for transplant; 100 days close monitoring
Recovery
100 days for initial engraftment period; 6-12 months for immune reconstitution
Average savings
84%
价格对比Price comparison

China versus the U.S.

China
$45,000
Range: $30,000–$60,000
United States
$275,000
Range: $150,000–$400,000
You save
84%
~$230,000 per procedure
China clinical rate
$30,000 – $60,000
$45,000
United States
$150,000 – $400,000
$275,000
You save
~84%
$230,000 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Allogeneic hematopoietic stem cell transplantation (HSCT) for acute and chronic leukemias using matched related, unrelated, or haploidentical donors. China's HSCT centers, particularly Peking University People's Hospital under the Beijing Protocol, have pioneered haploidentical transplantation techniques that achieve outcomes comparable to matched unrelated donor transplants, dramatically expanding the donor pool and reducing wait times for patients without a matched sibling.

流程Procedure steps

Step by step.

  1. 01

    Pre-Transplant Evaluation & Donor Search

    Disease restaging, organ function assessment, HLA typing, donor selection (sibling, unrelated, or haploidentical), and donor workup

    Duration · 2-4 weeks
  2. 02

    Conditioning Chemotherapy

    Myeloablative or reduced-intensity conditioning regimen to eliminate residual leukemia and create space for donor cells

    Duration · 5-10 days
  3. 03

    Stem Cell Infusion

    Infusion of donor peripheral blood stem cells or bone marrow, with GVHD prophylaxis initiated (cyclosporine, methotrexate, or PTCy)

    Duration · 1 day
  4. 04

    Engraftment & GVHD Management

    Monitoring for neutrophil and platelet engraftment, infection prophylaxis, GVHD surveillance, and chimerism testing

    Duration · 3-6 weeks inpatient + 100 days outpatient
Benefits
  • Pioneering haploidentical transplant expertise (Beijing Protocol)
  • Outcomes comparable to matched unrelated donor transplants
  • Expanded donor pool means nearly every patient has a donor option
  • Cost savings of 70-80% compared to US transplant programs
Considerations
  • Graft-versus-host disease (acute and chronic)
  • Severe infections during neutropenic period
  • Graft failure or relapse of leukemia
  • Long-term effects including infertility and secondary cancers
下一步Next step

Ask the AI for hospitals that handle stem cell transplant for leukemia.

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.